Announced financings: Sept. 5

Here’s your roundup of announced equity financings, courtesy of PrivatePlacements.com, the only database that tracks every financing, every day.

1. Medexus Pharmaceuticals Inc. (TSX: MDP)

• Gross Proceeds: $10 million
• Sector: Pharmaceuticals
• Units issued: 3.39 million
• Type: Special units
• Price: $2.95
• Warrants: Half; $3.65; 30 months
• Agents: Research Capital Corp.
• Use of Proceeds: Working capital

Company breakdown:

• Pharmaceutical company focused on oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.
• Earned US$700,000 in fiscal Q1 2024
• Testing "Ixinity" for treating severe hemophilia

2. Aston Bay Holdings Inc. (TSX-V: BAY)

• Gross Proceeds: $5 million
• Sector: Precious metals
• Units issued: 26.32 million
• Type: Special units
• Price: $0.19
• Warrants: Full; $0.29; Two years
• Agents: Cantor Fitzgerald Canada Corp.
• Use of Proceeds: Ongoing exploration

Company breakdown:

• Copper and gold junior with projects in Virginia and Nunavut
• Recently found a new copper discovery at its Storm project

3. Ramm Pharma Corp. (CSE: RAMM)

• Gross Proceeds: $1 million
• Sector: Cannabinoid pharmacology
• Units issued: 20 million
• Type: Special units
• Price: $0.05
• Warrants: Full; $0.05; Three years
• Agents: Non-brokered
• Use of Proceeds: Working capital

Company breakdown:

• Develops cannabis pharmaceuticals
• Lack of recent news